Managing Director and CFO changes with independent director reappointment

Ceo ResignedCfo ResignedKmp ResignedManagement Changes View source PDF Explain this filing

ASIANTNE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+13.3%Reaction day

₹9.70

prior close

₹10.60

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+13.0% vs market

Trading & Distributors peers, median of 132sector+0.0%+13.3% vs sector

On the reaction day the stock moved 13.0 pts more than Nifty Microcap 250 and 13.3 pts more than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.3

10m

+3.6

15m

+3.5

30m

+2.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+13.3+0.3+13.0+0.0+13.3

Next day

+7.0+0.6+6.4-0.1+7.1

+4.3-0.4+4.7-1.4+5.7

+0.5-0.9+1.5-1.6+2.1

+0.6-0.3+1.0-1.3+1.9

+0.4+0.3+0.1-0.8+1.2

-3.3+1.3-4.6-1.5-1.8

15d

-5.2-0.1-5.0-2.6-2.5

-5.2-1.2-3.9-3.0-2.2

-9.9-7.7-2.2-8.4-1.5

—————

UpDownMarket · Nifty Microcap 250Sector · Trading & Distributors peers, median of 132Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Hariram Garg will step down as Managing Director on 28 September 2026 for health reasons but remain Chairman and non-executive director, pending shareholder approval. His son Sunil will be Managing Director for five years. Independent director Akhil Kumar Manglik was reappointed for five years from 6 September 2026, pending shareholder approval. Rajesh Garg resigned as CFO on 7 September 2026 due to work commitments, and Raunak Garg replaced him.

Likely market impact

Planned succession and an immediate CFO replacement support continuity, though the health-linked MD exit and family appointments may concern investors.